Stanford Report, October 18, 2000
|Link appointed new
hematology/oncology chief at Stanford, Packard
Michael P. Link, MD, professor of pediatrics, has been appointed chief of the division of pediatric oncology, hematology and bone marrow transplantation for the School of Medicine, and director of oncology, hematology and bone marrow transplantation services at Lucile Salter Packard Children's Hospital.
Link continues the work of Bertil E. Glader, MD, PhD, who recently left the post to serve as the School of Medicine's associate dean of continuing education.
"Cancer and diseases of the blood remain a major cause of morbidity and mortality in children," said Harvey Cohen, MD, chair of the department of pediatrics. "Although the past two decades have brought us significant advances in the understanding of the basic biology of childhood cancer and new treatments, we want to make even greater strides in the future. Dr. Link will help guide this effort, in pediatrics, for Stanford."
"Dr. Link's breadth of knowledge and experience in the field prepare him well to lead Packard's continuing contributions to the treatment of life-threatening diseases in children," added Christopher Dawes, president and chief executive officer of Packard Children's Hospital.
Link earned his medical degree from Stanford in 1974. He completed an internship in medicine at Children's Hospital Medical Center, Boston, and served as both a clinical fellow and a research fellow in pediatrics at Harvard Medical School. He joined the faculty at Stanford in 1979 and for 10 years served as co-director of Packard's oncology program.
Link, a native of Cleveland, is active in several national organizations, including the Children's Oncology Group, American Society of Clinical Oncology and American Cancer Society. He also participates in a National Institutes of Health study section on clinical oncology.